U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948344) titled 'Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited Cardiomyopathy' on April 15.
Brief Summary: "Background Information Cardiomyopathy is one of the leading causes of heart failure. In cases where cardiomyopathy does not respond to guideline-directed medical therapy for heart failure, the disease may progress to a stage where heart transplantation is the only viable treatment option. According to the 2022 Korean Organ Transplant Registry (KOTRY) report, cardiomyopathy accounted for approximately 65% of heart transplant indications in Korea, making it one of the most challenging unresolved issues in modern cardiol...